Limits on patient eligibility are making it difficult for some primary care physicians to switch over from private insurance to direct primary care (DPC) practice models.

Biogen and Swedish Orphan Biovitrum AB (Sobi) have received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to market Elocta.

K2M Group Holdings Inc. has commercially launched its spinal technology.

AstraZeneca representatives gave presentations on oncology research at the 2015 European Cancer Congress (ECC) in Vienna.

After President Obama signed into law the Protecting Affordable Care for Employees Act, U.S. Sen. Tim Scott (R-SC) issued a statement supporting the measure on Thursday. "With the PACE Act quickly signed into law, we have taken a great step forward in protecting small and mid-size businesses from the harmful effects of Obamacare," Scott said.

New legislation was introduced recently by U.S. Sens. Bill Cassidy (R-LA) and Sheldon Whitehouse (D-RI) that they said would strengthen accountability and improve transparency in health information technology systems.

Researchers at the Technical University of Denmark's Systems Biology department have developed groundbreaking diagnostic technology that, based on a biopsy from a metastasis, can with 85 percent accuracy identify a cancer source. The new method relies on an analysis of DNA mutations in cancer tissue samples from patients with metastasized cancers.

U.S. Sen. Susan Collins (R-ME) took to the Senate floor on Thursday to show her support for the Mental Health Reform Act of 2015. Collins is the co-sponsor of the bipartisan measure, which would address the lack of resources for those struggling with mental illness, as well as improve coordination to help develop solutions that would lead to better outcomes for families dealing with mental illness.

Induced hypothermia therapy may even harm one's recovery.

These virtual reality models have been under development at the University of Montreal Hospital Research Center's radiology, radiation oncology and nuclear medicine departments.

The engagement between physicians and their patients is an important part of a successful health care outcome. To study how this can happen more effectively, the National Health Council and Genetic Alliance recently teamed up and invited a group of key officials to examine the issue and later released the group's findings in a white paper called "Dialogue/Advancing Meaningful Patient Engagement in Research, Development and Review of Drugs."

Expectant mothers worried about epidurals or spinal anesthesia during childbirth may have their fears reduced by a study that found the rate of anesthesia-related complications for cesarean delivery decreased 25 percent over the past 10 years. The findings were published Thursday in the online edition of Anesthesiology, the journal of the American Society of Anesthesiologists.

Last week two treatments aimed at lowering blood sugar in adult patients with diabetes mellitus --Tresiba and Ryzodeg 70/30 -- were approved by the U.S. Food and Drug Administration. About 21 million people in the United States are living with diabetes, which can increase the risk of health conditions such as heart disease, blindness, nerve and kidney damage.

Through a study conducted by researchers at University of New South Wales (UNSW) Australia and the University of Oxford, scientists have the capability to better predict how fast the HIV virus will reappear in a patient after treatment is halted. Results of the study were recently published in the journal Nature Communications.

The U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent application from Glytec for key aspects of the company's core technology for diabetes management; Glytec is an innovator in the field of glucose management software, and the Notice of Allowance is for a system for glycemic control of a diabetic patient that includes a smartphone-based diabetes mobile application.

Pharmaceutical manufacturer Allergan said Sept. 25 it is releasing a generic version of Janssen's Invega (paliperidone extended release tablets) in the U.S. Allergan , based in Dublin, Ireland, is the first company to receive U.S. Food and Drug Administration approval for a generic version of Invega, which is used to treat schizophrenia in patients aged 12-17.

Sen. Alexander -- along with 117 other lawmakers -- believe that the Stage 3 EHR program is being rushed to the detriment of many.

Roche subsidiary Genentech recently released results from three Phase III studies of ocrelizumab on patients with relapsing multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS).Data from two identical studies, OPERA I and OPERA II, were done using test subjects with relapsing MS.

Breastfeeding is widely considered the healthiest way to nourish a baby, and a recent report, published in Vital Signs and compiled by the U.S. Centers for Disease Control and Prevention (CDC), said that since 2007, hospital support for breastfeeding moms has been on the rise.

U.S. Sens. Sheldon Whitehouse (D-RI) and Bill Cassidy (R-LA) recently unveiled bipartisan legislation aimed at enhancing accountability and transparency in health information technology (IT) systems.